Reference: Anderson, S. (2020). CBER plans for monitoring COVID-19 vaccine safety and effectiveness. Vaccine and Related Biological Products Advisory Committee Meeting Presentation, October 22. FDA. Summary: The FDA’s Vaccines and Related Biological Products Advisory Committee meeting on October 22, 2020, provided insights into the agency’s plans for monitoring the safety and effectiveness of COVID-19 vaccines. […]
Reference: Malhotra, A. (2022). Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine – Part 2. Journal of Insulin Resistance, 5(1), a72. https://doi.org/10.4102/jir.v5i1.72 Summary: Aseem Malhotra’s article critiques the spread of misinformation surrounding COVID-19 mRNA vaccines, highlighting ethical concerns in medical practice and the failure of public health messaging. He argues
Reference: Turni, C., & Lefringhausen, A. (2022). COVID-19 vaccines – An Australian review. Journal of Clinical & Experimental Immunology, 7(3), 491-508. Summary: This review examines the safety and efficacy of COVID-19 mRNA vaccines from an Australian viewpoint. It contrasts initial promises made about the vaccines with actual outcomes, highlighting serious side effects including death, based
Reference: BioNTech Manufacturing GmbH. (2022). COVID-19 mRNA vaccine (nucleoside modified) Reporting Period Periodic Safety Update Report (PSUR) 3: 19 December 2021 through 18 June 2022. Summary: The third Periodic Safety Update Report (PSUR) for the COVID-19 mRNA vaccine (BNT162b2), also known as COMIRNATY®, covers data from 19 December 2021 to 18 June 2022. It outlines
Reference: South African National Department of Health. (2022). Rapid review report for COVID-19 vaccine 5–11-year-old children: Should the BNT162b2 COVID-19 vaccine be used for children aged 5 -11 years old in South Africa. Summary: A rapid review evaluated the efficacy and safety of the BNT162b2 COVID-19 vaccine for children aged 5-11 in South Africa. The
Reference: Kruse, P. (2022). Swissmedic criminal claim – Executive summary. K R U S E | L A W. Retrieved from https://coronacomplaint.ch/ Summary: The article details a criminal claim involving 37 complainants and six private claimants against Swissmedic regarding the mRNA vaccines. It asserts that the administration of these vaccines poses a significant health risk,
Reference: Kory, P., Marik, P., et al. (2022). I-RECOVER: Post-Vaccine Treatment protocol. Summary: The I-RECOVER protocol offers guidance for healthcare professionals treating patients experiencing post-vaccine syndrome, a condition with symptoms emerging or worsening following COVID-19 vaccination. Contributors, including prominent physicians, acknowledge the lack of formal recognition and classification for this syndrome by major health organisations,
Reference: Bekker, L.-G., Garrett, N., Goga, A., Fairall, L., Reddy, T., Yende-Zuma, N., Kassanjee, R., Collie, S., Sanne, I., Boulle, A., Seocharan, I., Engelbrecht, I., Davies, M.-A., Champion, J., Chen, T., Bennett, S., Mametja, S., Semenya, M., Moultrie, H., de Oliveira, T., Lessells, R. J., Cohen, C., Jassat, W., Groome, M., Von Gottberg, A., Le
Reference: Hayek, S., Shaham, G., Ben-Shlomo, Y., Kepten, E., Dagan, N., Nevo, D., Lipsitch, M., Reis, B. Y., Balicer, R. D., & Barda, N. (2022). Indirect protection of children from SARS-CoV-2 infection through parental vaccination. Science, 375(6585), 1155–1159. https://doi.org/10.1126/science.abm3087 Summary: The article investigates the indirect protection conferred to unvaccinated children against SARS-CoV-2 through parental vaccination